Production of insulin antibody associated with relapsed hodgkin’s lymphoma
Open Access
- 16 October 2021
- journal article
- case report
- Published by Springer Nature in Diabetology International
- Vol. 13 (2) , 456-460
Abstract
A 72-year-old man with type 2 diabetes mellitus with good glucose control for 20 years and maintained on oral hypoglycaemic agents was diagnosed with Hodgkin’s Lymphoma (HL) and started on insulin glargine for glycaemic control. Despite increased doses of insulin, his blood glucose levels went up dramatically. The anti-insulin antibody test proved to be positive, and Scatchard plot analysis showed 2 binding sites with relatively low-affinity constants: K1 = 0.0032, K2 = 0.0002 (108/M); and high binding capacities: R1 = 98.4, R2 = 372 (10−8 M), which were compatible with the features of antibody of insulin autoimmune syndrome (IAS). However, hypoglycaemia was not noted throughout the course of treatment. Since the insulin binding ratio of the antibody decreased from 87.3% to 62% after the termination of insulin treatment, it was suggested that the antibody reacted mainly to exogenously injected insulin. Switching insulin preparations or introducing insulin secretagogues did not improve elevated blood glucose levels. The initiation of brentuximab vedotin (BV), a therapeutic agent for relapsed HL, resulted in a remarkable improvement in glycaemic control despite the absence of insulin therapy and partial remission of HL. This case suggested that HL triggered anti-insulin antibody production, which resulted in poor glycaemic control, and that BV could be a new treatment option for autoimmune diseases associated with HL.Keywords
This publication has 32 references indexed in Scilit:
- Population‐based study of autoimmune conditions and the risk of specific lymphoid malignanciesInternational Journal of Cancer, 2009
- Binding characteristics and crossreactivity of insulin autoantibodies and insulin antibodies directed to three different insulin moleculesActa Diabetologica, 2008
- Autoimmunity and Susceptibility to Hodgkin Lymphoma: A Population-Based Case–Control Study in ScandinaviaJNCI: Journal of the National Cancer Institute, 2006
- A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapyDiabetes Research and Clinical Practice, 2006
- CD30 in Normal and Neoplastic CellsClinical Immunology, 1999
- Longitudinal Changes of Serum Insulin Concentration and Insulin Antibody Features in Persistent Insulin Autoimmune Syndrome (Hirata's Disease)Autoimmunity, 1994
- Brief Report: Hypoglycemia Due to a Monoclonal Insulin-Binding Antibody in Multiple MyelomaNew England Journal of Medicine, 1992
- Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsNature, 1982
- Insulin resistance and monoclonal gammopathyMetabolism, 1981
- INSULIN-I131 METABOLISM IN HUMAN SUBJECTS: DEMONSTRATION OF INSULIN BINDING GLOBULIN IN THE CIRCULATION OF INSULIN TREATED SUBJECTS 1Journal of Clinical Investigation, 1956